Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy

Venue: TBA

Location: New York, NY., United States

Event Date/Time: Oct 08, 2010 End Date/Time: Oct 10, 2010
Registration Date: Oct 07, 2010
Early Registration Date: Aug 30, 2010
Report as Spam

Description

The Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy congress will address emerging data that underlie the optimal management of early-stage and locally advanced breast cancer. The congress will include an in-depth discussion of the increasing number of breast cancer subtypes that challenge oncologists. A significant emphasis on case discussions and new data supporting adjuvant and neoadjuvant treatment options will provide a forum for discussion of the practical applicability of evolving clinical trial findings. Other topics pertaining to predictive biomarkers, staging, risk assessment, toxicity management, and survivorship will also be addressed.

The purpose of this congress is to provide an update on the latest advances in the management of early-stage and locally advanced breast cancer and to address key areas of controversy concerning treatment in those settings.

Target Audience

This educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

Topics to be included:

New Breast Cancer Subtypes

Claudin low
Molecular apocrine
Pleomorphic lobular
Micropapillary
Basal A/B
Local Therapies

Management of DCIS
Hypofractionated radiation therapy
Preoperative therapy decision points
Management of familial breast cancer
Systemic Therapies

Clinical implications of focal HER2 amplification
Chemotherapy in luminal vs. basal breast cancer
Who benefits from angiogenesis inhibitors?
Treating bone micrometastases
Endocrine therapy for life?
Promising novel targeted agents

Venue

TBA
New York
NY.
United States
MORE INFO ON THIS VENUE

Additional Information

Physicians: Physicians' Education Resource is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This activity is approved for AMA PRA Category 1 Creditâ„¢ Physician Assistants: AAPA accepts category 1 credit from AOACCME, Prescribed credit from AAFP, and AMA Category 1 CME credit for the PRA from organizations accredited by the ACCME.